About Orbimed
Orbimed is a Healthcare company based in New York (United States) founded in 1989. Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. Orbimed has completed 2 acquisitions, including Chemclin and Response Biomedical. Its website orbimed.com draws about 31 thousand monthly visits. Its Indian entity Orbimed Advisors India Private Limited reported revenue of ₹45.73 Cr. Orbimed offers products and services including Investment Services and Portfolio Management. Its focus areas include Medical Devices, Innovation, Device Manufacturing and Biopharmaceuticals.
Company details
OrbiMed has been recognized for investing globally in healthcare companies for over 25 years, focusing on biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. A team of over 130 professionals manages approximately 17 billion in assets across public and private investments from 12 locations. Efforts are directed towards driving innovation and improving patient outcomes by addressing unmet medical needs worldwide.
- Headquarters New York, United States
- SectorsHealthcare
- Website category Finance · Investing
- Email••••••••
- Phone•••• ••••
- Website orbimed.com
- Social LinkedIn X
- Legal Name Orbimed Advisors India Private Limited
- Date of Incorporation 23 Sep, 2008
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹45.73 Cr
FY 2025 · +73% YoY
- Indian entity net profit₹5.72 Cr
FY 2025 · 13% margin
- Indian entity EBITDA₹7.94 Cr
FY 2025 · 17% margin
- Investments & AcquisitionsChemclin
& 1 more
Associated legal entities of Orbimed
Orbimed operates through Orbimed Advisors India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Orbimed Advisors India Private Limited CIN U67120MH2008FTC186971 | Active | 23 Sep 2008 | Mumbai, Maharashtra | ₹45.7 Cr | 3 | View details |
Products & Services of Orbimed
Orbimed offers a comprehensive portfolio of products and services, including Investment Services and Portfolio Management.
Financing solutions are provided by OrbiMed to healthcare companies for innovation and development
Investments are managed by OrbiMed in healthcare sectors to address unmet medical needs
Board of directors of Orbimed Advisors India Private Limited (Orbimed)
Orbimed Advisors India Private Limited is the primary company behind Orbimed. The board of Orbimed Advisors India Private Limited currently have 3 directors; the longest-serving is Sunny Sharma, appointed in 2008. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunny Sharma DIN 02267273 | Director | 23 Sep 2008 | 18 yrs 1 mo | Orbimed Advisors India Private Limited |
| William Carter Neild DIN 08153626 | Director | 14 Jun 2018 | 8 yrs 4 mo | Orbimed Advisors India Private Limited |
| Sam Block Iii DIN 08501959 | Director | 09 Jul 2019 | 7 yrs 3 mo | Orbimed Advisors India Private Limited |
People of Orbimed
23 people are tracked at Orbimed (14 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Rishi Gupta | Partner | Leadership |
Andrew Kanarek | Chief Risk Officer | Leadership |
Carl L. Gordon | Managing Partner | Leadership |
Sven H. Borho | Managing Partner | Leadership |
Trevor M. Polischuk | Partner | Leadership |
Girish Bakhru | Executive Director | Leadership |
Erez Chimovits | Partner | Leadership |
Steven D. Wang | Partner | Leadership |
Matthew S. Rizzo | Partner | Leadership |
David Wang | Partner | Leadership |
Brian Glowatz | Director Of Tax | Leadership |
Corey Schrader | Vice President, Data Engineer | Leadership |
Daniel Rhee | Chief Technology Officer | Leadership |
Zack Mager | Vice President | Leadership |
Evans Meireles | Information Technology Systems Engineer | Team |
Alyson Nadir | Executive Assistant | Team |
Jessica Zhang | Senior Associate | Team |
Cason Kim | Quantitative Analyst | Team |
Stephen Pearn | Senior Controller | Team |
Christina Petrungaro | Executive Assistant | Team |
3 more people are available in the full profile.
Complete people profiles for Orbimed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Orbimed
Figures of Orbimed Advisors India Private Limited, the primary company behind Orbimed, for FY 2025. Revenue was ₹45.73 Cr (+73% year on year). Net profit was ₹5.72 Cr (13% margin). EBITDA was ₹7.94 Cr (17% margin). Revenue has grown at a compounded annual rate of +30% over three years and +20% over five years.
- ₹45.73 CrRevenue · FY 2025 · +73% YoY
- ₹5.72 CrNet profit · 13% margin
- ₹7.94 CrEBITDA · 17% margin
- ₹1.95 CrPaid-up capital
- +30%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Orbimed Advisors India Private Limited are on its company page.
Detailed financial statements for Orbimed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orbimed
Orbimed has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Chemclin and Response Biomedical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Rapid on-site diagnostic tests are developed, manufactured, and marketed. | responsebio.com | Vancouver, Canada | 1992 | Jun 2016 | $11M | |
In vitro diagnostic instruments and reagents are provided by Chemclin. | chemclin.com | Beijing, China | 2007 | Jun 2013 | •••• |
Complete acquisition details for Orbimed
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Orbimed
3 dated milestones of Orbimed across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Orbimed is founded.
- Acquisition Acquires Chemclin.
- Acquisition Acquires Response Biomedical.
Web traffic of Orbimed
The website of Orbimed (orbimed.com) receives about 30.6K visits a month and ranks #933,486 among all websites worldwide, #8,544 in Investing.
- Monthly visits30.6K
▲ 27.8% vs previous month
- Unique visitors9.8K
per month
- Global rank#933,486
among all websites
- Category rank#8,544
Finance · Investing
- Bounce rate32%
- Pages per visit3.5
- Average visit1 min 47 sec
- DevicesDesktop 50% · Mobile 50%
Websites whose visitors overlap most with Orbimed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nlvpartners.com | 100% | 2.3K | #6,681,039 | View details | |
| mpmcapital.com | 98% | View details | |||
| versantventures.com | 89% | #1,687,075 | View details | ||
| synogen.com | 84% | View details | |||
| altapartners.com | 83% | #5,912,934 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Orbimed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Medical Device Tech & Outsourcing
3 companies that operate in the same segment as Orbimed (Medical Device Tech & Outsourcing) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Home medical and respiratory equipment and supplies are distributed. | 2005 | Phoenixville, Pennsylvania, United States | USD 4 M | USD 3.24 B | 10,500 | |
Cybersecurity solutions for medical devices are provided by MedCrypt. | 2016 | San Diego, California, United States | USD 63.75 M | |||
Laboratory and production supplies and services are provided. | 1902 | Hampton, Virginia, United States | 592 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Orbimed
Complete news archive for Orbimed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orbimed
Orbimed was founded in 1989.
Orbimed is headquartered in New York, United States. It is registered at New York, New York, United States.
The primary company behind Orbimed, Orbimed Advisors India Private Limited, reported revenue of ₹45.73 Cr for FY 2025, up 73% year on year.
OrbiMed has been recognized for investing globally in healthcare companies for over 25 years, focusing on biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. A team of over 130 professionals manages approximately 17 billion in assets across public and private investments from 12 locations. Efforts are directed towards driving innovation and improving patient outcomes by addressing unmet medical needs worldwide.
Orbimed offers Investment Services and Portfolio Management.
Orbimed has made 2 acquisitions, including Chemclin, and Response Biomedical.
Orbimed operates through Orbimed Advisors India Private Limited.
The legal entities of Orbimed currently have 3 directors, including William Carter Neild, Sunny Sharma, Sam Block Iii.